中山大学附属第八医院麻醉科, 广东 深圳 518033
邓梦娟,第一作者,研究方向:多模式术后镇痛;麻醉治疗与睡眠,E-mail 1476958778@qq.com
收稿:2026-07-09,
修回:2026-08-27,
录用:2026-09-02,
纸质出版:2026-09-20
移动端阅览
邓梦娟,邓嘉丽,文诗坤等.羟考酮用于阻塞性睡眠呼吸暂停患者的术后镇痛[J].中山大学学报(医学科学版),2026,47(05):923-930.
DENG Mengjuan,DENG Jiali,WEN Shikun,et al.Oxycodone for Postoperative Analgesia in Patients With Obstructive Sleep Apnea Undergoing Uvulopalatopharyngoplasty[J].Journal of Sun Yat-sen University(Medical Sciences),2026,47(05):923-930.
邓梦娟,邓嘉丽,文诗坤等.羟考酮用于阻塞性睡眠呼吸暂停患者的术后镇痛[J].中山大学学报(医学科学版),2026,47(05):923-930. DOI: 10.11714/jsysu.med.YX20260099.
DENG Mengjuan,DENG Jiali,WEN Shikun,et al.Oxycodone for Postoperative Analgesia in Patients With Obstructive Sleep Apnea Undergoing Uvulopalatopharyngoplasty[J].Journal of Sun Yat-sen University(Medical Sciences),2026,47(05):923-930. DOI: 10.11714/jsysu.med.YX20260099.
目的
2
通过对比研究羟考酮和舒芬太尼在中重度阻塞性睡眠呼吸暂停综合征(OSA)患者术后镇痛效果及不良反应,来探讨羟考酮用于中重度阻塞性睡眠呼吸暂停综合征患者行悬雍垂腭咽成形术(UPPP)的安全性及有效性。
方法
2
选取2023年8月至2025年8月经多导睡眠监测(PSG)确诊为中、重度OSA且经我院耳鼻喉专业医师评估择期行全身麻醉下UPPP术的患者73例,采用随机数字表法分为羟考酮组(Ⅱ组)和舒芬太尼组(Ⅰ组),羟考酮组37例,舒芬太尼组36例。Ⅰ组予以舒芬太尼1.5 μg/kg,Ⅱ组予以羟考酮0.9 mg/kg,两组镇痛泵均配置为100 mL,手术结束前10 min给予负荷量2 mL,背景输注量2 mL/h,自控镇痛量2 mL/次,锁定时间8 min,极限量10 mL。记录术后4、12、24、48 h静息及吞咽疼痛数字评价量表(NRS)评分、Ramsay镇静评分、等效吗啡镇痛剂量、镇痛泵按压次数、患者静脉自控镇痛(PCIA)满意度、首次进食时间,以及呼吸抑制、恶心呕吐等镇痛相关不良反应。
结果
2
两组患者基线资料差异无统计学意义(
P
>0.05),具有可比性;术后各时
间点静息、吞咽NRS评分、Ramsay镇静评分、PCIA满意度、首次进食时间及不良反应发生率组间比较差异均无统计学意义(
P
>0.05);羟考酮组术后各时间点等效吗啡镇痛消耗量显著低于舒芬太尼组,术后24、48 h镇痛泵无效按压次数亦显著少于对照组,差异均有统计学意义(
P
<0.05)。
结论
2
低剂量羟考酮用于中重度OSA患者UPPP术后静脉自控镇痛,可获得与舒芬太尼相当的镇痛效果,两组术后不良反应、进食时间、满意度评分差异无统计学意义(
P
>0.05)。羟考酮组各类不良反应发生率及进食时间均低于舒芬太尼组,呈现更优的安全趋势,提示羟考酮用于该类患者的镇痛在降低不良事件发生风险以及促进快速康复方面具有潜在的临床优势。
Objective
2
To evaluate the safety and efficacy of oxycodone versus sufentanil for postoperative analgesia in patients with moderate to severe obstructive sleep apnea (OSA) undergoing uvulopalatopharyngoplasty (UPPP).
Methods
2
We enrolled 73 consecutive patients with moderate-to-severe OSA (confirmed by polysomnography) scheduled for elective UPPP under general anesthesia at our institution between August 2023 and August 2025. Patients were randomly assigned to receive oxycodone (
n
= 37) or sufentanil (
n
= 36) using a random number table . The sufentanil group received 1.5 μg per kilogram of body weight, and the oxycodone group received 0.9 mg per kilogram; both groups used patient-controlled intravenous analgesia (PCIA) pumps with a total volume of 100 mL. A 2 mL loading dose was administered 10 minutes before the end of surgery, followed by a background infusion of 2 mL per hour, 2 mL bolus doses on demand, an 8-minute lockout interval, and a maximum hourly volume of 10 mL. We assessed pain scores (Numerical Rating Scale) at rest and during swallowing, Ramsay sedation scores, morphine-equivalent opioid consumption, PCIA bolus demands, patient satisfaction, time to first oral intake, and adverse events (including respiratory depression, nausea, and vomiting) at 4, 12, 24, and 48 hours postoperatively.
Results
2
Baseline characteristics were well balanced between the two groups (all
P
>0.05). No significant between-group diffe
rences were observed in resting and swallowing NRS scores or Ramsay sedation scores at each postoperative time point, PCIA satisfaction, time to first oral intake, or adverse event incidence across all postoperative time points (all
P
>0.05). Morphine-equivalent opioid consumption was significantly lower in the oxycodone group at all time points, as were unsuccessful PCIA bolus demands at 24 and 48 hours postoperatively (both
P
<0.05).
Conclusions
2
Low-dose oxycodone provided analgesic efficacy similar to that of sufentanil for PCIA after UPPP in patients with moderate-to-severe OSA, with no significant between-group differences in adverse events, time to first oral intake, or satisfaction .The oxycodone group had numerically lower adverse event rates and a shorter time to first oral intake, suggesting a favorable safety profile and potential benefits for reducing opioid-related events and facilitating earlier recovery in this patient population.
Tolbert TM , Schmickl CN , Gell LK , et al . Research priorities for translating endophenotyping of adult obstructive sleep apnea to the clinic: an official American thoracic society research statement [J]. Am J Respir Crit Care Med , 2025 , 211 ( 9 ): 1562 - 1583 .
刘红霞 . 《成人阻塞性睡眠呼吸暂停诊治指南(2025)》概览 [J]. 中华医学信息导报 , 2026 , 41 ( 6 ): 7 .
Liu HX . An overview of the Guidelines for the diagnosis and treatment of obstructive sleep apnea in adults (2025) [J]. Chin Med News , 2026 , 41 ( 6 ): 7 .
Kaczmarski P , Karuga FF , Szmyd B , et al . The role of inflammation, hypoxia, and opioid receptor expression in pain modulation in patients suffering from obstructive sleep apnea [J]. Int J Mol Sci , 2022 , 23 ( 16 ): 9080 .
Zhong Z , Lu X , Zhang Q , et al . Obstructive sleep apnea and postoperative hyperalgesia in bariatric surgery: a prospective observational cohort study [J]. J Pain Res , 2025 , 18 : 4527 - 4538 .
Cozowicz C , Memtsoudis SG . Perioperative management of the patient with obstructive sleep apnea: a narrative review [J]. Anesth Analg , 2021 , 132 ( 5 ): 1231 - 1243 .
黄佳 , 黄浩贤 , 陆立基 , 等 . 阻塞性睡眠呼吸暂停综合征患者困难气道评估的研究 [J]. 实用医学杂志 , 2024 , 40 ( 10 ): 1460 - 1466 .
Huang J , Huang HX , Lu LJ , et al . Research of difficult airway assessment in patients with obstructive sleep apnea hypopnea syndrome [J]. J Pract Med , 2024 , 40 ( 10 ): 1460 - 1466 .
Stuck BA , Ravesloot MJL , Eschenhagen T , et al . Uvulopalatopharyngoplasty with or without tonsillectomy in the treatment of adult obstructive sleep apnea: a systematic review [J]. Sleep Med , 2018 , 50 : 152 - 165 .
秦敏菊 , 李卫星 , 张成 , 等 . 部分喉切除术患者使用羟考酮与吗啡静脉自控镇痛的有效性和安全性比较 [J]. 上海医学 , 2022 , 45 ( 3 ): 160 - 164 .
Qin MJ , Li WX , Zhang C , et al . Comparison of the efficacy and safety of oxycodone versus morphine for intravenous patient-controlled analgesia in patients undergoing partial laryngectomy [J]. Shanghai Med J , 2022 , 45 ( 3 ): 160 - 164 .
Lam KK , Kunder S , Wong J , et al . Obstructive sleep apnea, pain, and opioids: is the riddle solved? [J]. Curr Opin Anaesthesiol , 2016 , 29 ( 1 ): 134 - 140 .
中华医学会麻醉学分会五官科麻醉学组 . 阻塞性睡眠呼吸暂停患者围术期麻醉管理专家共识(2020修订版)快捷版 [J]. 临床麻醉学杂志 , 2021 , 37 ( 2 ): 196 - 199 .
Otorhinolaryngology Anesthesiology Group of the Chinese Society of Anesthesiology . Expert consensus on perioperative anesthesia management of patients with obstructive sleep apnea (2020 revised edition): concise version [J]. J Clin Anesthesiol , 2021 , 37 ( 2 ): 196 - 199 .
Feng X , Yang P , Liao Z , et al . Comparison of oxycodone and sufentanil in patient-controlled intravenous analgesia for postoperative patients: a meta-analysis of randomized controlled trials [J]. Chin Med J (Engl) , 2023 , 136 ( 1 ): 45 - 52 .
Yang GW , Cheng H , Song XY , et al . Effect of oxycodone-based multimodal analgesia on visceral pain after major laparoscopic gastrointestinal surgery: a randomised, double-blind, controlled trial [J]. Drug Des Devel Ther , 2024 , 18 : 1799 - 1810 .
Yao X , Wang Z , Zhang Y , et al . Oxycodone versus sufentanil for postoperative recovery in obese patients undergoing laparoscopic bariatric surgery: a randomized controlled trial [J]. Drug Des Devel Ther , 2025 , 19 : 9387 - 9397 .
孙豪君 , 谭思琪 , 邹彬 , 等 . 羟考酮用于全髋关节置换术后皮下自控镇痛的有效性和安全性研究 [J]. 联勤军事医学 , 2026 , 40 ( 2 ): 161 - 165 ; + 199 .
Sun HJ , Tan SQ , Zou B , et al . A Study on the efficacy and safety of oxycodone for subcutaneous patient-controlled analgesia after total hip arthroplasty [J]. Mil Med Joint Logist , 2026 , 40 ( 2 ): 161 - 165 ; + 199 .
Bolden N , Posner KL , Domino KB , et al . Postoperative critical events associated with obstructive sleep apnea: results from the Society of Anesthesia and Sleep Medicine Obstructive Sleep Apnea Registry [J]. Anesth Analg , 2020 , 131 ( 4 ): 1032 - 1041 .
Tao B , Liu K , Wang D , et al . Effect of intravenous oxycodone versus sufentanil on the incidence of postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery [J]. J Clin Pharmacol , 2019 , 59 ( 8 ): 1144 - 1150 .
Chen HY , Wang ZN , Zhang WY , et al . Advances in the clinical application of oxycodone in the perioperative period [J]. World J Clin Cases , 2022 , 10 ( 16 ): 5156 - 5164 .
中华医学会外科学分会 , 中华医学会麻醉学分会 . 中国加速康复外科临床实践指南(2021版) [J]. 中国实用外科杂志 , 2021 , 41 ( 9 ): 961 - 992 .
Chinese Society of Surgery , Chinese Medical Association ; Chinese Society of Anesthesiology , Chinese Medical Association . Clinical practice guidelines for enhanced recovery after surgery in China (2021 edition) [J]. Chin J Pract Surg , 2021 , 41 ( 9 ): 961 - 992 .
Jia W , Wang Z , Lin Y , et al . Effects of oxycodone versus sufentanil-based intravenous patient-controlled multimodal analgesia on early gastrointestinal recovery and pain after laparoscopic colorectal cancer surgery: a randomized double-blind trial [J]. J Pain Res , 2026 , 19 : 591268 .
Gupta K , Nagappa M , Prasad A , et al . Risk factors for opioid-induced respiratory depression in surgical patients: a systematic review and meta-analyses [J]. BMJ Open , 2018 , 8 ( 12 ): e024086 .
中华医学会麻醉学分会疼痛学组 . 羟考酮注射液临床应用专家共识(2025版) [J]. 中华医学杂志 , 2025 , 105 ( 44 ): 4024 - 4040 .
Pain Group of the Chinese Society of Anesthesiology . Expert consensus on the clinical application of oxycodone injection (2025 edition) [J]. Natl Med J China , 2025 , 105 ( 44 ): 4024 - 4040 .
Dang SJ , Li RL , Wang J , et al . Oxycodone vs sufentanil in patient-controlled intravenous analgesia after gynecological tumor operation: a randomized double-blind clinical trial [J]. J Pain Res , 2020 , 13 : 937 - 946 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
